Vivozon Healthcare Inc (082800) — Cash Flow-to-Debt Ratio
Vivozon Healthcare Inc (082800) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2025, meaning its operating cash flow of ₩-1.47 Billion could theoretically repay 0% of its total liabilities (₩92.82 Billion) in one year. See Vivozon Healthcare Inc (082800) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Vivozon Healthcare Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Vivozon Healthcare Inc across 12 annual periods. Also explore 082800 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Vivozon Healthcare Inc (2014–2025)
Year-by-year debt coverage analysis for Vivozon Healthcare Inc. For market capitalisation and broader financial context, see Vivozon Healthcare Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.07x | ₩-6.87 Billion | ₩92.82 Billion | ▼ -200.7% |
| 2024 | 0.07x | ₩5.73 Billion | ₩78.02 Billion | ▲ +70.8% |
| 2023 | 0.04x | ₩2.99 Billion | ₩69.58 Billion | ▲ +205.1% |
| 2022 | -0.04x | ₩-3.32 Billion | ₩81.24 Billion | ▲ +74.4% |
| 2021 | -0.16x | ₩-17.50 Billion | ₩109.35 Billion | ▼ -585.6% |
| 2020 | 0.03x | ₩4.62 Billion | ₩140.36 Billion | ▲ +147.1% |
| 2019 | -0.07x | ₩-3.89 Billion | ₩55.66 Billion | ▲ +50.9% |
| 2018 | -0.14x | ₩-4.59 Billion | ₩32.21 Billion | ▲ +37.0% |
| 2017 | -0.23x | ₩-4.59 Billion | ₩20.31 Billion | ▼ -174.0% |
| 2016 | 0.31x | ₩5.87 Billion | ₩19.22 Billion | ▲ +163.8% |
| 2015 | 0.12x | ₩2.78 Billion | ₩24.05 Billion | ▼ -24.9% |
| 2014 | 0.15x | ₩3.03 Billion | ₩19.64 Billion | — |